| Prostate Cancer Foundation Australia |
Well informed men aged 50–69 years |
From age 45 years for men with 2.5–3 times increased risk (eg, a brother diagnosed, particularly if diagnosed at age < 60 years), or age 40 years for those with nine to ten times increased risk (eg, father and two brothers diagnosed) |
Men aged > 70 years or those with a life expectancy < 15 years |
| European Association of Urology |
Well informed men aged ≥ 50 years |
From age 45 years for men with family history of prostate cancer or men of African descent, and from age 40 years for men carrying BRCA2 mutations |
Men ≥ 70 years or those with a life expectancy < 15 years |
| American Urological Association |
Well informed men aged 55–69 years |
For men younger than 55 years at higher risk (African American, family history of metastatic prostate cancer, genetic mutations) screening should be individualised |
Men < 40 years, men > 70, or those with < 10–15‐year life expectancy |
| National Comprehensive Cancer Network |
Men aged 55–69 years |
From age 45–75 years for average risk patients, and from age 40–75 years for African American patients or those with germline mutations |
Men aged < 40 years, men > 70 years, or those with < 10–15‐year life expectancy |